Clinical Trial Update: To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the pharmacodynamics, safety, and pharmacokinetics of pazopanib eye drops in adults with neovascular age-related macula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2017-09-28